How to assess hemostasis in patients with severe liver disease

被引:1
|
作者
Lisman, Ton [1 ,2 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Surg Res Lab, Groningen, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Sect Hepatobiliary Surg & Liver Transplantat, Groningen, Netherlands
关键词
CRITICALLY-ILL PATIENTS; THROMBIN GENERATION; CIRRHOSIS; TESTS; RISK;
D O I
10.1182/hematology.2023000479
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Patients with advanced liver dis eases fre quently acquire pro found alter ations in their hemo static sys tem. Simultaneous changes in procoagulant and anti co ag u lant sys tems result in a reset in the hemo static bal ance with a rel a tively neu tral net effect, although there are nota ble hypocoagulable and hyper co ag u la ble fea tures in the hemo static sys tem in patients with liver dis ease. Laboratory and clin i cal stud ies have dem on strated that patients have a rel a tively well- pre served hemo static sys tem even though rou tine diag nos tic tests of hemo sta sis (pro throm bin time, plate let count) sug gest a bleed ing ten dency. Routine diag nos tic tests of hemo sta sis are unsuit able to assess the hemo static sta tus of patients with liver dis ease, as these tests are insen si tive for the con cur rent prohemostatic and antihemostatic changes in these patients. These tests are, how ever, fre quently requested in patients with liver dis ease, as they are well established indi ca tors of sever ity of liver dis ease. This paper will dis cuss com monly used diag nos tic and research- type hemo static tests and will out line how test results should be interpreted in patients with liver dis ease.
引用
收藏
页码:267 / 273
页数:7
相关论文
共 50 条
  • [31] Severe liver disease in HIV patients -: Epidemiology and diagnosis
    Bourlière, M
    MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 : 1 - 3
  • [32] ORKAMBI IN PATIENTS WITH CYSTIC FIBROSIS AND SEVERE LIVER DISEASE
    Lim, A.
    Balouch, F.
    Cheney, J.
    Lewindon, P.
    Roberts, J.
    Schneider
    Shevill
    Wainwright, C.
    RESPIROLOGY, 2020, 25 : 156 - 156
  • [33] ORKAMBI IN PATIENTS WITH CYSTIC FIBROSIS AND SEVERE LIVER DISEASE
    Lim, A.
    Balouch, F.
    Cheney, J.
    Lewindon, P.
    Roberts, J.
    Schneider, E.
    Shevill, E.
    Wainwright, C.
    RESPIROLOGY, 2021, 26 : 156 - 156
  • [34] ABNORMAL LIVER-FUNCTION TESTS - HOW TO ASSESS THEIR IMPORTANCE IN ASYMPTOMATIC PATIENTS
    KOOLS, AM
    BLOOMER, JR
    POSTGRADUATE MEDICINE, 1987, 81 (06) : 45 - 51
  • [35] How to assess atherosclerotic plaque activity in ischemic heart disease patients?
    Ristic, T.
    Cosic, V.
    Ilic, M. Deljanin
    Djordjevic, V.
    Vlahovic, P.
    CLINICA CHIMICA ACTA, 2024, 558
  • [36] Management of hemostasis abnormalities in patients with liver failure
    Ozier, Y.
    Cadic, A.
    Dovergne, A.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2013, 20 (02) : 249 - 254
  • [37] HEMOSTASIS ACTIVATION IN PATIENTS WITH LIVER-CIRRHOSIS
    VUKOVICH, T
    TEUFELSBAUER, H
    FRITZER, M
    KREUZER, S
    KNOFLACH, P
    THROMBOSIS RESEARCH, 1995, 77 (03) : 271 - 278
  • [38] PORTAL INFLAMMATION IS AN INDEPENDENT PREDICTOR OF SEVERE LIVER DISEASE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
    Kang, Hellan
    Greenson, Joel K. K.
    Huang, Mary Ann Y.
    Omo, Jason
    Conjeevaram, Hari S.
    HEPATOLOGY, 2009, 50 (04) : 779A - 779A
  • [39] Rebalanced Hemostasis in Patients with Acute Liver Failure
    Lisman, Ton
    Stravitz, R. Todd
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (05): : 468 - 473